Gossamer Bio, Inc.
GOSS· Nasdaq
GOSSGossamer Bio, Inc.
Filed Feb 26, 2021 · 10-K · 57 days after period end · 0001728117-21-000019
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 |
|---|---|---|---|
| Net Income | -$64.60M | -$54.70M | -$38.79M |
| EPS Diluted | — | -$0.89 | -$4.92 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Gossamer Bio, Inc. · CIK 1728117 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Feb 26, 2021 · 57 d after period end
